Press releases
- Orthofix to Participate in Canaccord Genuity's 44th Annual Growth Conference
- Orthofix Names Stephanie Walsh Chief Human Resources Officer
- Orthofix to Report Second Quarter 2024 Financial Results
- Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System
- Michael Finegan Named Chair of the Orthofix Board of Directors
- Aviva McPherron Joins Orthofix as President of Global Operations and Quality
- Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer; Max Reinhardt Begins as President of Global Spine
- Orthofix Names Max Reinhardt President of Global Spine Business
- Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program
- Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail
More ▼
Key statistics
As of last trade Orthofix Medical Inc (OM2:FRA) traded at 14.80, -23.32% below its 52-week high of 19.30, set on Sep 05, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.80 |
---|---|
High | 14.80 |
Low | 14.80 |
Bid | 14.80 |
Offer | 15.40 |
Previous close | 14.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 37.53m |
Free float | 35.63m |
P/E (TTM) | -- |
Market cap | 611.35m USD |
EPS (TTM) | -3.40 USD |
Data delayed at least 15 minutes, as of Jul 24 2024 07:06 BST.
More ▼